2022-09-30 Psychedelic Chronicle

Tryp Therapeutics Add 2 New Provisional Patents to Intellectual Property Portfolio

Recently, clinical-stage psychedelic biotechnology company Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) filed for two new provisional patents strengthening the company’s intellectual property portfolio. The company which focuses on developing psilocybin-based medicines for illnesses with unmet medical needs announced the 2 patents via press release. The first #63/405,786 is a patent application for the use of psilocybin to treat patients with fibromyalgia while the other patent, #63/375,305 expands the intellectual property related to the company’s development of TRP-8803. About Tryp Therapeutics Tryp Therapeutics is a cutting-edge biotechnology company that is focused on developing molecules related to psilocybin to treat diseases The post Tryp Therapeutics Add 2 New Provisional Patents to Intellectual Property Portfolio appeared first on Psychedelic Chronicle.

External link. We are not responsible for the content.

Read more ↗

More From Psychedelic Chronicle

2023-02-16 Psychedelic Chronicle

Choose Ketamine Complete Capital Raise to Expand Technology Platform

In a major milestone for mental health care, Austin-based Choose Your Horizon Inc., also known as Choose Ketamine, ha...

2022-10-14 Psychedelic Chronicle

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

The well-known psychedelic biotech company Biomind Labs Inc. (NEO: BMND) (OTC: BMNDF) (FSE: 3XI) announced that it ha...

2022-10-11 Psychedelic Chronicle

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced today that it has beg...

Latest News

2026-05-29 The Microdose (Berkeley)

Veterans Affairs announces new MDMA clinical trial; Psilocybin’s antidepressant effects are both rapid and long-lasting

Plus: Psychedelic trips leave traces in speech through vocal “jitter” and “shimmer;" Scientists pair intravenous keta...

2026-05-29 The Psychedelic Blog (Substack)

What Do Psychedelics Want From Us?

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.

2026-05-29 DoubleBlind Magazine

Dads Are Tripping and It’s Making Them Better Fathers

Here's what can happen when dads stop performing and start feeling. [...] Read More... The post Dads Are Tripping and...

2026-05-28 Microdose (industry)

Medical Psilocybin Act

New York lawmakers are officially considering the “Medical Psilocybin Act,” legislation that would create legal acces...

2026-05-27 DoubleBlind Magazine

Is New York About to Become a Medical Psilocybin Pioneer?

The bill just needs to reach the floor...and the clock is ticking. [...] Read More... The post Is New York About to B...

2026-05-25 DoubleBlind Magazine

Are Some Drugs Really More Criminal or Just More Policed?

PLUS stories about psychedelic assisted therapy for journalists, psychedelic dioramas, and a 5-MeO-DMT workshop you d...